In non-diabetic mice, GLP-1 infusion increased GFR by reducing preglomerular resistance [20], an observation that could potentially explain the physiological increase in GFR observed in the postprandial compared to the fasting state, although human studies infusing GLP-1 peptide could not replicate this observation [21]
The success of clinical trials with exenatide and liraglutide sparked growing interest in therapies based on GLP-1
Common types of nanoformulations include liposomes, polymeric nanoparticles, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nano-emulsions, micelles, dendrimers, nanocrystals, and nano-complexes [32]
Vaccines Kennedy's numerous remarks, anti-vaccine nonprofit and lawsuits against immunizations are likely to haunt him